Christina Kay

2023

In 2023, Christina Kay earned a total compensation of $301.3K as Co, Chief Executive Officer at Integrated Biopharma, a 9% increase compared to previous year.

Compensation breakdown

Bonus$6,400
Option Awards$48,225
Salary$237,273
Other$9,417
Total$301,315

Kay received $237.3K in salary, accounting for 79% of the total pay in 2023.

Kay also received $6.4K in bonus, $48.2K in option awards and $9.4K in other compensation.

Rankings

In 2023, Christina Kay's compensation ranked 2,377th out of 2,770 executives tracked by ExecPay. In other words, Kay earned more than 14.2% of executives.

ClassificationRankingPercentile
All
2,377
out of 2,770
14th
Division
Manufacturing
1,321
out of 1,516
13th
Major group
Chemicals And Allied Products
773
out of 855
10th
Industry group
Drugs
753
out of 821
8th
Industry
Pharmaceutical Preparations
536
out of 590
9th
Source: SEC filing on October 27, 2023.

Kay's colleagues

We found three more compensation records of executives who worked with Christina Kay at Integrated Biopharma in 2023.

2023

Dina Masi

Integrated Biopharma

Chief Financial Officer

2023

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

2023

E Kay

Integrated Biopharma

Chairman

News

You may also like